{"text": "TITLE:\n      COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland\nSUMMARY:\n      In the light of ONTARGET and TRANSCEND studies results, it would be interesting to\n      investigate the real-life telmisartan treatment tolerability. It is well known and accepted\n      that the Real-life setting is much more adequate to reflect the antihypertensive and safety\n      properties of the drug in comparison to the organized and scheduled setting of the clinical\n      trial. Because there are not much data on the cough in relation to telmisartan, therefore it\n      would we worth to observe the cough frequency and general treatment tolerance in patients\n      treated with telmisartan, who had to stop their previous ACE-I treatment due to cough.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria: - hypertension\n          -  age > 18\n          -  ACE-I related cough Exclusion Criteria: - Current treatment with telmisartan\n          -  Cholestatic disorders and severe hepatic failure\n          -  Allergy to telmisartan\n          -  Pregnancy and lactation period\n", "cuis": "C0857121 C0947663 C0248719 C0087111 C1533734 C3887704 C0746919 C0032357 C0723457 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C1552616 C1706244 C0543488 C0947630 C0275586 C4050469 C0248719 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C3845898 C0003364 C0857121 C0558058 C3887804 C0013227 C1254351 C0086960 C1555711 C3272565 C3887804 C0248719 C0010200 C0687152 C3245479 C0233492 C0018792 C0199174 C0220929 C0231197 C0231199 C1547317 C1744706 C0013220 C0020963 C0010200 C0687152 C2347273 C3898838 C0248719 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0010200 C0687152 C0332155 C0243161 C0013893 C0020538 C1963138 C1696708 C2748577 C0947663 C0243161 C0248719 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0243161 C0010200 C0687152 C0233492 C0445356 C0085605 C0012634 C0007222 C0017178 C1306232 C0248719 C0020517 C0718579 C1527304 C3539909 C0032961 C3484365 C0425965 C3843687 C3843688 C3843689 C3843690 C3843691 C3843692 C0025344 C0043084 C0006147 ", "concepts": "Hypertensive, Hypertensin, Telmisartan, treatment, Treatment, treatment, No Treatment, Poland, Stop, Patient, Patient, Patient, Patient, Patient, Patient summary, summary interesting, studies, blight, Slight telmisartan, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, Uknown antihypertensive, hypertensive, reflect, upsetting drug, drug, schedule, organizer, Clinical, upsetting telmisartan, cough, coughs, data, elation, Atrial general treatment, Tolerance, Tolerance, intolerances, Intolerance, intolerance, Tolerance, Tolerance, cough, coughs, Frequency, Frequency telmisartan, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, cough, coughs, untreated criteria, Eligibility hypertension, Hypertension, Prehypertensions, No hypertension, hypertensin, Criteria telmisartan, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, Criteria, cough, coughs, elated, Unrelated hepatic failure, disorders, CV disorders, GI disorders, severed telmisartan, Allergy., Allergy, Allergy, Allergy pregnancy, Pregnancy, ? Pregnancy, Pregnancy 6, Pregnancy 5, Pregnancy 4, Pregnancy 3, Pregnancy 2, Pregnancy 1, period, Ablactation, Lactation "}
